Brian Adams - Net Worth and Insider Trading

Brian Adams Net Worth

The estimated net worth of Brian Adams is at least $2 Million dollars as of 2024-11-06. Brian Adams is the Chief Legal Officer of Relay Therapeutics Inc and owns about 321,907 shares of Relay Therapeutics Inc (RLAY) stock worth over $2 Million. Brian Adams is also the General Counsel and Secretary of Keryx Biopharmaceuticals Inc and owns about 126,069 shares of Keryx Biopharmaceuticals Inc (KERX) stock worth over $423,592. Details can be seen in Brian Adams's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Adams has not made any transactions after 2024-10-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Brian Adams

To

Brian Adams Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian Adams owns 2 companies in total, including Relay Therapeutics Inc (RLAY) , and Keryx Biopharmaceuticals Inc (KERX) .

Click here to see the complete history of Brian Adams’s form 4 insider trades.

Insider Ownership Summary of Brian Adams

Ticker Comapny Transaction Date Type of Owner
RLAY Relay Therapeutics Inc 2024-10-28 General Counsel
KERX Keryx Biopharmaceuticals Inc 2018-02-15 General Counsel and Secretary

Brian Adams Latest Holdings Summary

Brian Adams currently owns a total of 2 stocks. Among these stocks, Brian Adams owns 321,907 shares of Relay Therapeutics Inc (RLAY) as of October 28, 2024, with a value of $2 Million and a weighting of 81.89%. Brian Adams also owns 126,069 shares of Keryx Biopharmaceuticals Inc (KERX) as of February 15, 2018, with a value of $423,592 and a weighting of 18.11%.

Latest Holdings of Brian Adams

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RLAY Relay Therapeutics Inc 2024-10-28 321,907 5.95 1,915,347
KERX Keryx Biopharmaceuticals Inc 2018-02-15 126,069 3.36 423,592

Holding Weightings of Brian Adams


Brian Adams Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian Adams has made a total of 32 transactions in Relay Therapeutics Inc (RLAY) over the past 5 years, including 1 buys and 31 sells. The most-recent trade in Relay Therapeutics Inc is the sale of 1,632 shares on October 28, 2024, which brought Brian Adams around $9,890.

According to the SEC Form 4 filings, Brian Adams has made a total of 0 transactions in Keryx Biopharmaceuticals Inc (KERX) over the past 5 years. The most-recent trade in Keryx Biopharmaceuticals Inc is the sale of 5,652 shares on February 15, 2018, which brought Brian Adams around $27,186.

Insider Trading History of Brian Adams

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian Adams Trading Performance

GuruFocus tracks the stock performance after each of Brian Adams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian Adams is -9.05%. GuruFocus also compares Brian Adams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian Adams within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Brian Adams's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Brian Adams

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.86 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -17.97 LIMIT LIMIT LIMIT LIMIT LIMIT

Brian Adams Ownership Network

Ownership Network List of Brian Adams

No Data

Ownership Network Relation of Brian Adams

Insider Network Chart

Brian Adams Owned Company Details

What does Relay Therapeutics Inc do?

Who are the key executives at Relay Therapeutics Inc?

Brian Adams is the General Counsel of Relay Therapeutics Inc. Other key executives at Relay Therapeutics Inc include Vice President & Finance Thomas Catinazzo , See remarks Peter Rahmer , and See Remarks Donald A Bergstrom .

Relay Therapeutics Inc (RLAY) Insider Trades Summary

Over the past 18 months, Brian Adams made 11 insider transaction in Relay Therapeutics Inc (RLAY) with a net sale of 9,973. Other recent insider transactions involving Relay Therapeutics Inc (RLAY) include a net sale of 132,111 shares made by Peter Rahmer , a net sale of 44,032 shares made by Thomas Catinazzo , and a net sale of 18,539 shares made by Donald A Bergstrom .

In summary, during the past 3 months, insiders sold 22,688 shares of Relay Therapeutics Inc (RLAY) in total and bought 0 shares, with a net sale of 22,688 shares. During the past 18 months, 291,361 shares of Relay Therapeutics Inc (RLAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 291,361 shares.

Relay Therapeutics Inc (RLAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Relay Therapeutics Inc Insider Transactions

No Available Data

Brian Adams Mailing Address

Above is the net worth, insider trading, and ownership report for Brian Adams. You might contact Brian Adams via mailing address: 750 Lexington Avenue, New York Ny 10022.